Home | Contact Us | Site Map
  Recent News:  
  March 20, 2008  
  NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis  
  March 17, 2008  
  NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis  
  March 06, 2008  
  NanoBio Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones  
  February 26, 2008  
  Nasal Vaccine for Smallpox Confers High Levels of Immunity without Safety Risks  
  More News  
     
  NanoBio Presentations, 2008 American Academy of Dermatology  
 

Posters: Clinical and Preclinical Studies on NB-001, Herpes Labialis and NB-002, Onychomycosis

  
 

 

Career Opportunities:

  
  Open Positions at NanoBio  

BlueLine

Company | Platform Technology | Anti-infectives | Vaccines | Careers | News

© NanoBio® Corporation 2008
NanoBio is a registered trademark of NanoBio Corporation.
All other company, brand, and product names are or may be trademarks of their respective holders. Website by Mellon & Associates, LLC.